Beacon Pointe Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Beacon Pointe Advisors, LLC

$8.35 Billion
Q2 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 19,181 shares of VRTX stock, worth $8.88 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

19,181

Previous 19,189 0.04%

Holding current value

$8.88 Million

Previous $8.02 Million 12.08%

% of portfolio

0.11%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $3,142 - $3,884	-8 Reduced 0.04%	19,181 $8.99 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $30,576 - $33,456	-75 Reduced 0.39%	19,189 $8.02 Million
Q4 2023 Feb 08, 2024	SELL	$343.0 - $410.68 $278,859 - $333,882	-813 Reduced 4.05%	19,264 $7.84 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $244,842 - $262,421	724 Added 3.74%	20,077 $6.98 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $551,178 - $616,898	-1,753 Reduced 8.31%	19,353 $6.81 Million
Q1 2023 May 12, 2023	SELL	$283.23 - $323.1 $1.48 Million - $1.69 Million	-5,230 Reduced 19.86%	21,106 $6.65 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $156,024 - $175,528	-546 Reduced 2.03%	26,336 $7.61 Million
Q3 2022 Nov 09, 2022	SELL	$273.83 - $305.53 $81,327 - $90,742	-297 Reduced 1.09%	26,882 $7.79 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $176,924 - $220,290	-753 Reduced 2.7%	27,179 $7.66 Million
Q1 2022 May 17, 2022	BUY	$221.42 - $260.97 $1.2 Million - $1.41 Million	5,414 Added 24.04%	27,932 $7.29 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $1.12 Million - $1.41 Million	-6,314 Reduced 21.9%	22,518 $4.95 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $3.24 Million - $3.62 Million	17,845 Added 162.42%	28,832 $5.23 Million
Q2 2021 Aug 17, 2021	BUY	$187.49 - $221.1 $1.79 Million - $2.11 Million	9,536 Added 657.2%	10,987 $2.22 Million
Q1 2021 May 18, 2021	BUY	$207.02 - $241.31 $14,491 - $16,891	70 Added 5.07%	1,451 $313,000
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $37,882 - $50,524	-183 Reduced 11.7%	1,381 $327,000
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $41,415 - $49,102	162 Added 11.55%	1,564 $426,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $2,931 - $3,845	13 Added 0.94%	1,402 $408,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $277,480 - $344,208	1,389 New	1,389 $329,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Vertex Pharmaceuticals Inc Transaction History